Tuesday 26 January 2021

Reuters Health Report: Eli Lilly's antibody combination reduces risk of death from COVID-19: study

Reuters.com Newsletter

Eli Lilly's antibody combination reduces risk of death from COVID-19: study

Eli Lilly and Co said on Tuesday treatment with a combination of two of its antibodies helped reduce risk of hospitalizations and death due to COVID-19 by 70%, according to results from a late-stage trial.

Regeneron's antibody cocktail effective in preventing COVID-19 infection: study

Regeneron Pharmaceuticals Inc said on Tuesday its antibody cocktail was effective in preventing COVID-19 in people exposed to those infected with the new coronavirus, based on interim results from a late-stage study.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

Johnson & Johnson promises 2021 profit jump, vaccine data "soon"

Johnson & Johnson on Tuesday forecast 2021 profit above Wall Street estimates and promised data from its widely watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19.

No serious COVID-19 cases among Israelis given Pfizer shot, minister says

Israel, which has already given a full set of Pfizer/BioNTech vaccinations to over 6% of its citizens, has not registered a single serious COVID-19 case among them, even as infections surge in the wider population, the government said on Tuesday.

Norway cancels military manoeuvres to prevent spread of COVID-19

Norway has called off two military exercises involving primarily NATO troops in its Arctic region in order to contain the spread of the coronavirus, the government said on Tuesday.

Iran approves Russian coronavirus vaccine Sputnik V for use

Iranian Foreign Minister Mohammad Javad Zarif said on Tuesday that Tehran had approved the Russian Sputnik V coronavirus vaccine for domestic use.

Germany backs EU export restrictions on vaccine after supply cuts

Germany's health minister supported European Union proposals to introduce restrictions on COVID-19 vaccines on Tuesday as tensions grew with AstraZeneca and Pfizer over sudden supply cuts just a month after the bloc started vaccinating citizens.

English health service chief says restrictions on EU vaccine exports would be a worry

Any move by the European Union to limit vaccine exports to Britain would be a worry and jeopardise the target of vaccinating the most vulnerable by mid-February, an English health chief said on Tuesday.

WHO experts issue recommendations on Moderna COVID-19 vaccine

A World Health Organization (WHO) panel of experts recommended on Tuesday that the Moderna COVID-19 vaccine be given in two doses at an interval of 28 days, which could be extended under exceptional circumstances to 42 days.

France's Veran: sticking with decision to have 21-days gaps between two Pfizer shots

French Health Minister Olivier Veran said on Tuesday that he had decided to maintain to 21-28 days the gap between the injection of the first and the second dose of the Pfizer vaccine against COVID-19.

Related Videos

U.S. to join COVAX and remain WHO member - Fauci

Exhausted Nigerian doctors wait for vaccines

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS